Updated: 2012-04-30 17:09:51
May is Arthritis Action Month, held to draw attention to the more than 100 forms of arthritis that afflict at least 50 million people in the United States and collectively cost more to treat than cancer. Mayo Clinic invites the public … Continue reading →
Updated: 2012-04-29 18:53:25
NEW ORLEANS -- Accidental fetal exposure to natalizumab did not appear associated with adverse effects in pregnant multiple sclerosis patients, according to small studies presented here.
Updated: 2012-04-27 23:06:33
NEW ORLEANS -- Among patients with relapsing-remitting multiple sclerosis, little clinical benefit was seen for combining glatiramer acetate with interferon beta-1a versus either drug alone in a large randomized trial.
Updated: 2012-04-27 14:03:13
NEW ORLEANS -- The clinical course of multiple sclerosis does not appear to be affected by advent of menopause, researchers said here.
Updated: 2012-04-26 21:32:34
NEW ORLEANS -- Occlusions in cerebrospinal veins imaged with ultrasound and magnetic resonance venography do not appear to be related to multiple sclerosis, researchers said here.
Updated: 2012-04-26 19:48:39
The Mayo Clinic 2011 Annual Report, “What the Mayo Effect Means to Me,” now is available in print and online. The report features: Five personal stories and stories about patient care, research, education and innovation at Mayo Clinic A review … Continue reading →
Updated: 2012-04-26 14:58:17
NEW ORLEANS -- Being a woman and being young at diagnosis of multiple sclerosis were key hallmarks that allowed for "benign" disease over two decades or more, researchers said here.
Updated: 2012-04-25 23:01:49
NEW ORLEANS -- Dimethyl fumarate (BG-12) showed good efficacy and safety in the pivotal, phase III CONFIRM trial, in line with results from an earlier phase III study.
Updated: 2012-04-25 21:29:12
NEW ORLEANS -- Alemtuzumab (Lemtrada, Campath) dramatically reduced multiple sclerosis relapses in patients with long-term disease -- with just once-a-year treatment, researchers reported here.
Updated: 2012-04-25 21:14:22
Obesity and the painful autoimmune disorder rheumatoid arthritis are each becoming more common, raising a logical question: Could one have something to do with the other? For women, it appears there is a link, Mayo Clinic researchers say. They studied hundreds of … Continue reading →
Updated: 2012-04-25 16:53:05
In this video, Dr. Kelly Flemming discusses a stroke program that was studied at the Mayo Clinic. Patients in the stroke prevention program were likelier to follow a prescribed diet and exercise than those receiving traditional care, Mayo researchers … Continue reading →
Updated: 2012-04-25 16:44:36
NEW ORLEANS -- Multiple sclerosis patients treated with natalizumab were more likely to discontinue therapy after learning of a positive JCV antibody result, only to see a higher risk for relapse, according to a single-center study.
Updated: 2012-04-25 00:22:39
NEW ORLEANS -- Outcomes for multiple sclerosis patients in relapse and treated with oral methylprednisolone were no different than those of similar patients who received intravenous steroids, researchers found.
Updated: 2012-04-24 19:11:12
In this video, Dr. Brian Moseley discusses a study of a new structured sign out system for resident shift changes. The study was presented at the American Academy of Neurology annual meeting in New Orleans. In the study, junior residents … Continue reading →
Updated: 2012-04-23 17:20:32
His Holiness the Dalai Lama will visit the Rochester, Minn. campus of Mayo Clinic on Tuesday, April 24. While here, he will discuss the topic of resilience through mindfulness during a special presentation at the Saint Marys Hospital Chapel from 10 … Continue reading →
Updated: 2012-04-23 16:23:33
In the limited time of an office visit, how can a primary care physician make the case to parents that their child should be vaccinated? During National Infant Immunization Week, a Mayo Clinic vaccine expert and a pediatrician offer suggestions for … Continue reading →
Updated: 2012-04-21 16:00:00
The European Medicines Agency has called for stronger safety warnings for the multiple sclerosis drug fingolimod (Gilenya), and drugmaker Novartis said the FDA has agreed to similar label updates.
Updated: 2012-04-18 01:40:40
Three Mayo Clinic conferences focused on health care delivery – The Quality Academy Conference, The Conference on Systems Engineering/Operations Research in Health Care and The Mayo Clinic Health System Quality Innovation Conference – will be combined into a single event … Continue reading →
Updated: 2012-04-16 17:52:05
JACKSONVILLE, Fla. — A new class of molecular mutation, in various forms of breast cancer, has been discovered by Mayo Clinic researchers in Florida. This finding may shed new light on the growth of different types of breast tumors and investigators believe the discovery could … Continue reading →
